Colin P. Diong

Hematology | Oncology

825 Eastlake Ave E
Seattle, WA 98109

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Upfront memory T cell add-back with haploidentical TCRαβ-depleted graft in adults with haematological malignancies: a nationwide, multicentre, single-arm, prospective study.

Upfront memory T cell add-back with haploidentical TCRαβ-depleted graft in adults with haematological malignancies: a nationwide, multicentre, single-arm, prospective study.

Journal: Bone marrow transplantation

Published: April 20, 2025

Long-term survival and clinical implications of allogeneic stem cell transplantation in relapse/refractory lymphoma: A 20-year Singapore experience.

Long-term survival and clinical implications of allogeneic stem cell transplantation in relapse/refractory lymphoma: A 20-year Singapore experience.

Journal: Annals of the Academy of Medicine, Singapore

Published: January 31, 2025

AL amyloidosis: Singapore Myeloma Study Group consensus guidelines on diagnosis, treatment and management.

AL amyloidosis: Singapore Myeloma Study Group consensus guidelines on diagnosis, treatment and management.

Journal: Annals of the Academy of Medicine, Singapore

Published: June 26, 2024

Treatment outcomes of T and natural-killer/T-cell lymphoma with ifosfamide, carboplatin and etoposide chemotherapy.

Treatment outcomes of T and natural-killer/T-cell lymphoma with ifosfamide, carboplatin and etoposide chemotherapy.

Journal: Cancer reports (Hoboken, N.J.)

Published: March 28, 2021

Measurable residual disease in chronic lymphocytic leukemia: expert review and consensus recommendations.

Measurable residual disease in chronic lymphocytic leukemia: expert review and consensus recommendations.

Journal: Leukemia

Published: April 17, 2020

Mobilization kinetics of peripheral blood stem cells with rescue plerixafor - real-world experience from a single center.

Mobilization kinetics of peripheral blood stem cells with rescue plerixafor - real-world experience from a single center.

Journal: Leukemia & lymphoma

Published: February 25, 2020

Real world experience of R-CHOP with or without consolidative radiotherapy vs DA-EPOCH-R in the first-line treatment of primary mediastinal B-cell lymphoma.

Real world experience of R-CHOP with or without consolidative radiotherapy vs DA-EPOCH-R in the first-line treatment of primary mediastinal B-cell lymphoma.

Journal: Cancer medicine

Published: February 22, 2019

Donor-type fresh frozen plasma is effective in preventing hemolytic reaction in major ABO incompatible allogeneic stem cell transplant.

Donor-type fresh frozen plasma is effective in preventing hemolytic reaction in major ABO incompatible allogeneic stem cell transplant.

Journal: Transfusion

Published: December 20, 2017

Corrigendum: CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes.

Corrigendum: CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes.

Journal: Scientific reports

Published: April 08, 2017

Long-term renal outcome after allogeneic hemopoietic stem cell transplant: A comprehensive analysis of risk factors in an Asian patient population.

Long-term renal outcome after allogeneic hemopoietic stem cell transplant: A comprehensive analysis of risk factors in an Asian patient population.

Journal: Clinical transplantation

Published: January 21, 2017

Respiratory virus infection after allogeneic hematopoietic stem cell transplant in a tropical center: Predictive value of the immunodeficiency scoring index.

Respiratory virus infection after allogeneic hematopoietic stem cell transplant in a tropical center: Predictive value of the immunodeficiency scoring index.

Journal: Transplant infectious disease : an official journal of the Transplantation Society

Published: September 11, 2016

An exploration of the applicability of the refined disease risk index and its integration with other independent risk factors for individualized prognostication.

An exploration of the applicability of the refined disease risk index and its integration with other independent risk factors for individualized prognostication.

Journal: Bone marrow transplantation

Published: June 28, 2016

Showing 1-12 of 21

Last Updated: 09/26/2026